Medical Treatments for Rheumatoid Arthritis
Links shared publicly online about this topic.
- 850total visits
Medical Treatments for Rheumatoid Arthritis
View full resource at hivehealthmedia.com
Tags: Arthritis, Rheumatoid Arthritis, Healthy Living, Exercise and Fitness
Most Recently Shared on September 24, 2010 at 7:06 pm By:
#health, #fitness Medical Treatments for Rheumatoid Arthritis: Years ago, if a person was diagnosed with rheumatoi... http://bit.ly/aRacyY
New Drug for Rheumatoid Arthritis Favored by FDA Panel - Yahoo! News
news.yahoo.com — “From Yahoo! News: For those who have rheumatoid arthritis and are just not getting any benefits from their current treatment regimen, there could be hope on the horizon. A major drug company, Pfizer, has developed a new drug that has received FDA panel favor. This does not mean that the FDA will definitely approve it.” View full resource at news.yahoo.com
Most Recently Shared on May 12, 2012 at 7:44 am By:
New Drug for Rheumatoid Arthritis Favored by FDA Panel: For those who have rheumatoid arthritis and are just not... http://t.co/QmqUK6js
MedWire News - Bone Health - Biologics no better than DMARDs for refractory RA
medwire-news.md — “MedWire News Biologic treatment offers little long-term clinical benefit over conventional treatment for patients with rheumatoid arthritis who fail to respond to initial methotrexate therapy, Swedish researchers report. MedWire News” View full resource at medwire-news.md
Most Recently Shared on May 12, 2012 at 7:07 am By:
Biologics no better than DMARDs for refractory RA: Biologic treatment offers little long-term clinical benefit o... http://t.co/WanydNSR
Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug - Health News - redOrbit
redorbit.com — “An advisory panel recommends that the FDA consider approving Pfizer’s pill to treat rheumatoid arthritis. The pill, tofacitinib, would be sold to patients who don’t respond to traditional rheumatoid arthritis treatments.” View full resource at redorbit.com
Most Recently Shared on May 11, 2012 at 7:41 pm By:
Advisory Panel Recommends FDA Approval Of Rheumatoid Arthritis Drug: Connie K. Ho for http://t.co/6eqBD5l3 An adv... http://t.co/d6SkusIQ
FDA Panel in Favor of First JAK Inhibitor for RA
painlive.com — “The FDA Arthritis Advisory Committee voted to recommend approval of tofacitinib, a new treatment for moderate to severe rheumatoid arthritis (RA), Pfizer announced.” View full resource at painlive.com
Most Recently Shared on May 11, 2012 at 4:00 pm By:
FDA Panel in Favor of First JAK Inhibitor for RA http://t.co/rlqs8u3o
Is it typical to be extraordinarily tired after an Enbrel injection? This is only my second self-injection, but I'm finding myself worn out. - Biologic Medications - Rheumatoid Arthritis
healthcentral.com — “Questions and answers on Rheumatoid Arthritis. Get the answers you need from doctors, Experts and community members on MyRACentral.com.” View full resource at healthcentral.com
Most Recently Shared on May 11, 2012 at 2:48 pm By:
Many #RA meds, including Biologics, such as Enbrel, can make you tired for a day or so after you take them http://t.co/WIe1MI4x
FDA panel urges approval for Pfizer arthritis drug - Yahoo! News
news.yahoo.com — “From Yahoo! News: An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.” View full resource at news.yahoo.com
Most Recently Shared on May 10, 2012 at 1:34 am By:
FDA panel urges approval for Pfizer arthritis drug: An advisory committee to the US Food and Drug Administration... http://t.co/FlnNPjEd
Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment. | ResearchGate
researchgate.net — “Publication » Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment..” View full resource at researchgate.net
Most Recently Shared on May 9, 2012 at 2:02 pm By:
Is Enbrel safe in pregnancy ? http://t.co/pNufla2q #rheum #lupus
Dr. John M. Davis III « Mayo Clinic Medical Edge Radio
radio.mayoclinic.org — “Dr. John M. Davis III « Mayo Clinic Medical Edge Radio” View full resource at radio.mayoclinic.org
Most Recently Shared on May 8, 2012 at 3:12 pm By:
Medical edge Weekend w Dr. John Davis. Discussing types of #arthritis & how its diagnosed. 5/12/12 9-10a CT http://t.co/hxFCC6gi #mayoradio
FDA staff question Pfizer arthritis drug benefits | Reuters
in.reuters.com — “WASHINGTON (Reuters) - U.S. drug reviewers on Monday questioned whether the benefits of Pfizer Inc's experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections.The” View full resource at in.reuters.com
Most Recently Shared on May 7, 2012 at 2:36 pm By:
FDA staff question Pfizer arthritis drug benefits http://t.co/WXFuqyft
Psoriasis treatments: Overcoming fear of side effects - National Psoriasis Foundation
psoriasis.org — “Learn about treating psoriasis and the different treatment options for psoriasis. Several medical treatment options for psoriasis do exist and many alternative psoriasis treatment options are widely used.” View full resource at psoriasis.org
Most Recently Shared on May 4, 2012 at 8:18 pm By:
How to address the fear of side effects w/ treatment for #psoriasis & psoriatic #arthritis: http://t.co/XWsybp5u
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial : The Lancet
thelancet.com — “Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial. B...” View full resource at thelancet.com
Most Recently Shared on May 4, 2012 at 6:36 pm By:
[Articles] Conventional combination treatment versus biological treatment in methotrexate-refractory early rheum... http://t.co/eQiIWYgz
Lower All-Cause, Cardio Mortality in Obese With RA
painlive.com — “Overweight and obese patients with rheumatoid arthritis (RA) have lower all-cause and cardiovascular mortality, but have substantially increased risks of comorbidities, medical costs, and reduced quality of life compared with normal-weight RA patients, according to a study published online April 18 in Arthritis Care & Research.” View full resource at painlive.com
Most Recently Shared on May 3, 2012 at 1:30 pm By:
Lower All-Cause, Cardio Mortality in Obese With RA http://t.co/lMHLGJ0S
Study: RA Hurts More Than Physicians Realize : Rheumatology News
rheumatologynews.com — “Over 8,000 rheumatologists and selected internists rely on Rheumatology News monthly to cover the world of medicine with breaking news, on-site medical meeting coverage, and expert perspectives in print and online. Since 2002, our independent reporting has focused on impacting the way these specialists practice medicine. New multi-format programs with the quality and reputation of Rheumatology News offer sponsors opportunities to reach physicians with podcasts, newswires, e-newsletters, and cust” View full resource at rheumatologynews.com
Most Recently Shared on May 1, 2012 at 8:45 pm By:
A new study has shown that rheumatoid arthritis hurts even more than most physicians realize - http://t.co/xgmQDsls
Non-surgical Treatment of Spondylosis (Spinal Osteoarthritis
spineuniverse.com — “Very few patients with spondylosis (spinal osteoarthritis) require surgery. Non-surgical therapies are tried first and are often successfully alleviate the patient's symptoms. Article covers medications, physical therapy, chiropractic, and exercises” View full resource at spineuniverse.com
Most Recently Shared on April 30, 2012 at 8:20 pm By:
#Acupuncture, medications, and other non-surgical treatment options for spondylosis (spinal #arthritis): http://t.co/cLJ6uiOZ
Enrollment complete in Zalicus Synavive Phase 2b clinical trial for rheumatoid arthritis
news-medical.net — “Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced it has completed enrollment with 292 patients enrolled in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).” View full resource at news-medical.net
Most Recently Shared on April 30, 2012 at 6:18 pm By:
Arthritis News: Enrollment complete in Zalicus Synavive Phase 2b clinical trial for rheumatoid arthritis: Zalicu... http://t.co/RMkrrbrn
Advertisement

